{
    "paper_id": "PMC7079969",
    "metadata": {
        "title": "Synthesis and biological evaluation of 2-(5-substituted-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-N-substituted-hydrazinecarbothioamides",
        "authors": [
            {
                "first": "Subhas",
                "middle": [
                    "S."
                ],
                "last": "Karki",
                "suffix": "",
                "email": "subhasskarki@gmail.com",
                "affiliation": {}
            },
            {
                "first": "Amol",
                "middle": [
                    "A."
                ],
                "last": "Kulkarni",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Sujeet",
                "middle": [],
                "last": "Kumar",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Suresh",
                "middle": [
                    "Kumar"
                ],
                "last": "Veliyath",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Erik",
                "middle": [],
                "last": "De Clercq",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Jan",
                "middle": [],
                "last": "Balzarini",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Isatin has been known for about 150 years and has recently been found, like 2,3-dioxo-indoles and endogenous polyfunctional heterocyclic compounds, to exhibit biological activity in mammals (Somogyi, 2001). Schiff bases and Mannich bases of isatin are known to possess a wide range of pharmacological properties including antibacterial (Pandeya et al.,\n1998; Sarangapani and Reddy, 1994; Varma and Nobles, 1975), anticonvulsant (Sridhar et al.,\n2002; Varma et al.,\n2004), anti-HIV (Pandeya et al.,\n1998, 1999a, b, 2000; Sriram et al.,\n2000), antifungal (Pandeya et al.,\n1999a, b), antiviral (Singh et al.,\n1983), and anticancer activity (Fig. 1) (Karki et al.,\n2004, 2007, 2009). A variety of 3-substituted indolin-2-ones have been utilized as anticancer drugs or drug candidates (Mologni et al.,\n2010, Beauchard et al.,\n2009, Zhang and Go 2009, Andreani et al.,\n2010). A representative member of this class is sunitinib [SU11248, Sutent\u2122; Pfizer, Inc.] which is currently used in the clinics as a multi-targeting tyrosine kinase inhibitor with antiangiogenic activity (Fig. 1) (Sun et al.,\n2003). 6-Methoxycarbonyl group-substituted indolin-2-ones [BIBF1000, BIBF1120] are potent inhibitors of VEGFR-1/2/3, PDGFRa, and FGFR-1, with low cross-reactivity against a panel of other kinases (Fig. 1) (Roth et al.,\n2009). While BIBF1120 is currently being evaluated in phase III clinical trials in the treatment of non-small cell lung cancer and is in clinical development for other tumor types. Indirubin was identified as the active ingredient of a traditional Chinese recipe [Danggui Longhui Wan] that was used for the treatment of chronic myelogenous leukemia (CML) (Fig. 1) (Xiao et al.,\n2002).\n",
            "cite_spans": [
                {
                    "start": 200,
                    "end": 204,
                    "mention": "2001",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 353,
                    "end": 357,
                    "mention": "1998",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 382,
                    "end": 386,
                    "mention": "1994",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 406,
                    "end": 410,
                    "mention": "1975",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 445,
                    "end": 449,
                    "mention": "2002",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 465,
                    "end": 469,
                    "mention": "2004",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 498,
                    "end": 502,
                    "mention": "1998",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 504,
                    "end": 509,
                    "mention": "1999a",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 511,
                    "end": 512,
                    "mention": "b",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 514,
                    "end": 518,
                    "mention": "2000",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 535,
                    "end": 539,
                    "mention": "2000",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 570,
                    "end": 575,
                    "mention": "1999a",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 577,
                    "end": 578,
                    "mention": "b",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 606,
                    "end": 610,
                    "mention": "1983",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 661,
                    "end": 665,
                    "mention": "2004",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 667,
                    "end": 671,
                    "mention": "2007",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 673,
                    "end": 677,
                    "mention": "2009",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 797,
                    "end": 801,
                    "mention": "2010",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 821,
                    "end": 825,
                    "mention": "2009",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 840,
                    "end": 844,
                    "mention": "2009",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 863,
                    "end": 867,
                    "mention": "2010",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 1091,
                    "end": 1095,
                    "mention": "2003",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 1310,
                    "end": 1314,
                    "mention": "2009",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 1688,
                    "end": 1692,
                    "mention": "2002",
                    "ref_id": "BIBREF17"
                }
            ],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 643,
                    "end": 644,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 1075,
                    "end": 1076,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 1293,
                    "end": 1294,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 1671,
                    "end": 1672,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Thiosemicarbazones of various aldehydes and ketones occupy a special place among organic ligands, since they contain various donor atoms and are able to change density depending on the starting reagents and their reaction conditions. Isatin-3-thiosemicarbazones (1H-indole-2,3-dioxo-3-thiosemicarbazones) have been studied extensively due to their important biological activities (Karki et al.,\n2009), since 1-methylisatin-3-thiosemicarbazone (Marboran) was found to be active in the treatment of smallpox. Previous studies by our group have revealed the promising cytotoxic, and anticonvulsant properties of various 2,3-dioxo-2,3-dihydroindole thiosemicarbazones (Fig. 1) (Karki et al.,\n2009). Therefore, we have performed the synthesis of new N-4-aryl thiosemicarbazone derivatives of substituted 2,3-dioxo-2,3-dihydroindoles and evaluated them for cytotoxic, antiviral, and antimicrobial activity.",
            "cite_spans": [
                {
                    "start": 395,
                    "end": 399,
                    "mention": "2009",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 688,
                    "end": 692,
                    "mention": "2009",
                    "ref_id": "BIBREF22"
                }
            ],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 670,
                    "end": 671,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "The compounds in series 4 and 5 were prepared by the methodologies outlined in Scheme 1. The synthesis of 1-[(diethylamino)methyl]-1H-indole-2,3-dione derivatives (3) was carried out by mannich base reaction of 2,3-dioxy-2,3-dihydroindoles or 5-chloro-2,3-dioxy-2,3-dihydroindoles (2) with diethylamine in the presence of formaldehyde. The synthesis of N-diethylaminomethyl-2-oxo-1,2-dihydroindole hydrazinecarbothioamides (4a, b, 5a\u2013h) was carried out by reacting 1-[(diethylamino)methyl]-1H-indole-2,3-dione derivatives (3) with thiosemicarbazide and N\n4-aryl thiosemicarbazides under reflux in ethanol in the presence of catalytic amounts of glacial acetic acid. 1H-NMR spectroscopy indicated that the compounds exist as single isomers in solution.\n",
            "cite_spans": [],
            "section": "Chemistry ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 86,
                    "end": 87,
                    "mention": "1",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "All of the compounds were assayed for cytotoxicity against human HeLa and CEM T-lymphocytes as well as murine L1210 cells. These data are summarized in Table 1. Compound 5c was the most cytostatic among all compounds evaluated against the tumor cell lines (IC50 in the low micromolar range (1.9\u20134.4 \u03bcM)).\n",
            "cite_spans": [],
            "section": "Biological activity ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 158,
                    "end": 159,
                    "mention": "1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "The most potent inhibitor of murine L1210 cell proliferation (5c) was also the most inhibitory to human T-lymphocyte (CEM) and HeLa cell proliferation. The introduction of R\n2-benzyl substitution in the thiosemicarbazone derivative of series 5 often led to more potent inhibitors of tumor cell proliferation (5a\u2013h). Replacement of the hydrogen by chlorine atom did not improve the potentiation of the cytostatic activity (compare 5a with 5b) (Table 1). Whereas, replacement of the chlorine atom at R\n2 by a methoxy group often resulted in a marked (equal) potentiation of cytostatic activity (5b with 5c).",
            "cite_spans": [],
            "section": "Biological activity ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 449,
                    "end": 450,
                    "mention": "1",
                    "ref_id": "TABREF0"
                }
            ]
        },
        {
            "text": "Replacement of hydrogen atom at R\n1 by chlorine atom did not yield any improvement in potency (compare 5a, 5b and 5d with 5e\u2013h). Replacing hydrogen atom at R\n1 and R\n2 by chlorine resulted in a complete loss of activity (5f). By keeping chlorine atom at R\n1 and CH3 and OCH3 at R\n2, resulted in slight improvement of cytostatic activity (5g and 5h).",
            "cite_spans": [],
            "section": "Biological activity ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "The antiviral screening of 4a, b and 5a\u2013h was performed using an MTS-based CPE reduction assay (Kumar et al.,\n2010) against feline corona virus (FIPV) and feline herpes virus in CRFK cell culture; herpes simplex virus-1 (KOS) (HSV-1 KOS), herpes simplex virus-2 (G) (HSV-2G), vaccinia virus (VV), vesicular stomatitis virus (VSV), and herpes simplex virus-1 TK KOS ACVr (HSV-1 TK KOS ACVr) in HEL cell cultures; VSV, Coxsackie virus B4 (CV-B4), and respiratory syncytial virus (RSV) in HeLa cell cultures; influenza A virus H1N1 subtype, influenza A virus H3N2 subtype, and influenza B virus in MDCK cell cultures; parainfluenza-3 virus (PI-3V), reovirus-1 (RV-1), Sindbis virus (SV), CV-B4, and Punta Toro virus (PTV) in Vero cell cultures.",
            "cite_spans": [
                {
                    "start": 110,
                    "end": 114,
                    "mention": "2010",
                    "ref_id": "BIBREF23"
                }
            ],
            "section": "Biological activity ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "Compounds 4b, 5a, 5b, and 5d exhibited moderate antiviral activity in HEL cells in comparison to standard compounds. No specific antiviral effects were noted for any of the compounds in CRFK, MDCK, or Vero cell cultures (Tables 2, 3, 4, 5, 6).\n\n\n\n\n",
            "cite_spans": [],
            "section": "Biological activity ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 228,
                    "end": 229,
                    "mention": "2",
                    "ref_id": "TABREF1"
                },
                {
                    "start": 231,
                    "end": 232,
                    "mention": "3",
                    "ref_id": "TABREF2"
                },
                {
                    "start": 234,
                    "end": 235,
                    "mention": "4",
                    "ref_id": "TABREF3"
                },
                {
                    "start": 237,
                    "end": 238,
                    "mention": "5",
                    "ref_id": "TABREF4"
                },
                {
                    "start": 240,
                    "end": 241,
                    "mention": "6",
                    "ref_id": "TABREF5"
                }
            ]
        },
        {
            "text": "All the synthesized compounds were screened for \u03b2-lactamase inhibitory activity and results are shown in Table 1. Compounds namely 5a and 5g were capable of inactivating \u03b2-lactamase activity, and for other compounds activity was moderate in comparing to standard potassium clavulanate. Titled compounds were also screened for antibacterial activity against S. aureus, B. subtilis, K. pneumoniae, E. coli, P. vulgaris, and S. typhi and antifungal activity against A. niger and C. albicans and exhibited moderate antimicrobial activity (Table 7).\n",
            "cite_spans": [],
            "section": "Biological activity ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 111,
                    "end": 112,
                    "mention": "1",
                    "ref_id": "TABREF0"
                },
                {
                    "start": 541,
                    "end": 542,
                    "mention": "7",
                    "ref_id": "TABREF6"
                }
            ]
        },
        {
            "text": "The synthesis of the intermediate 2,3-dioxo-2,3-dihydroindoles was accomplished using a literature methodology (Marvel and Heirs, 1941) and a previously reported procedure was used to convert these compounds to the corresponding 1-[(diethylamino)methyl]-1H-indole-2,3-dione. The N\n4-arylthiosemicarbazides required for the preparation of 4a, b and 5a\u2013h was prepared by a literature methodology (Sen and Sengupta, 1962; Lieber et al.,\n1957).",
            "cite_spans": [
                {
                    "start": 130,
                    "end": 134,
                    "mention": "1941",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 413,
                    "end": 417,
                    "mention": "1962",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 434,
                    "end": 438,
                    "mention": "1957",
                    "ref_id": "BIBREF24"
                }
            ],
            "section": "Syntheses of the intermediate 2,3-dioxy-2,3-dihydroindoles ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "% Yield: 83, m.p.: 134\u2013136 \u00b0C; IR (KBr) (cm\u22121): 1131 (C=S), 1307 (C\u2013N), 1696 (C=O), 3005 (C\u2013H), 3143 (NH), 3238, 3256 (NH2); 1H-NMR (CDCl3) \u03b4 (ppm): 1.0 (t, 6H, 2CH3), 2.4 (q, 4H, 2CH2), 4.03 (s, 2H, N\u2013CH2), 7.0\u20137.7 (m, 4H, Ar\u2013H), 9.53 (s, 2H, NH2), 11.18 (s, 1H, NH); calc. for C14H19N5OS: C-55.06, H-6.27 and N-22.93, found C-55.18, H-6.15 and N-22.69.",
            "cite_spans": [],
            "section": "2-(1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)hydrazinecarbothioamide (4a) ::: General procedure for syntheses of 4a, b ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "% Yield: 64, m.p.: 214\u2013216 \u00b0C; IR (KBr) (cm\u22121): 1127 (C=S), 1305 (C\u2013N), 1698 (C=O), 3008 (C\u2013H), 3136 (NH), 3227, 3246 (NH2); 1H-NMR (CDCl3) \u03b4 (ppm): 1.0 (t, 6H, 2CH3), 2.4 (q, 4H, 2CH2), 4.03 (s, 2H, N\u2013CH2), 7.0\u20137.7 (m, 3H, Ar\u2013H), 9.53 (s, 2H, NH2), 11.18 (s, 1H, NH); calc. for C14H18ClN5OS: C-49.48, H-5.34 and N-20.61, found C-49.34, H-5.21 and N-20.69.",
            "cite_spans": [],
            "section": "2-(5-chloro-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)hydrazinecarbothioamide (4b) ::: General procedure for syntheses of 4a, b ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "% Yield: 69, m.p.: 230\u2013232 \u00b0C; IR (KBr) (cm\u22121): 1127 (C=S), 1304 (C\u2013N), 1713 (C=O), 3008 (C\u2013H), 3143, 3217 (NH); 1H-NMR (CDCl3) \u03b4 (ppm): 1.0 (t, 6H, 2CH3), 2.4 (q, 4H, 2CH2), 4.03 (s, 2H, N\u2013CH2), 6.9\u20137.7 (m, 9H, Ar\u2013H), 11.29 (s, 1H, N\u2013NH), 11.52 (s, 1H, NH); calc. for C20H23N5OS: C-62.97, H-6.08 and N-18.36, found C-62.53, H-5.87 and N-18.15.",
            "cite_spans": [],
            "section": "2-(1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide (5a) ::: General procedure for syntheses of 5a\u2013h ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "% Yield: 74, m.p.: 151\u2013153 \u00b0C; IR (KBr) (cm\u22121): 1129 (C=S), 1317 (C\u2013N), 1716 (C=O), 3006 (C\u2013H), 3128, 3209 (NH); 1H-NMR (CDCl3) \u03b4 (ppm): 1.0 (t, 6H, 2CH3), 2.4 (q, 4H, 2CH2), 4.03 (s, 2H, N\u2013CH2), 6.4\u20137.7 (m, 8H, Ar\u2013H), 11.29 (s, 1H, N\u2013NH), 11.52 (s, 1H, NH); calc. for C20H22ClN5OS: C-57.75, H-5.33 and N-16.84, found C-57.39, H-5.26 and N-16.53.",
            "cite_spans": [],
            "section": "N-(4-chlorophenyl)-2-(1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)hydrazine carbothioamide (5b) ::: General procedure for syntheses of 5a\u2013h ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "% Yield: 77, m.p.: 177\u2013179 \u00b0C; IR (KBr) (cm\u22121): 1119 (C=S), 1325 (C\u2013N), 1706 (C=O), 3008 (C\u2013H), 3120, 3202 (NH); 1H-NMR (CDCl3) \u03b4 (ppm): 1.0 (t, 6H, 2CH3), 2.4 (q, 4H, 2CH2), 3.75 (s, 3H, O\u2013CH3), 4.03 (s, 2H, N\u2013CH2), 6.3\u20137.7 (m, 8H, Ar\u2013H), 11.29 (s, 1H, N\u2013NH), 11.52 (s, 1H, NH); calc. for C21H25N5O2S: C-61.29, H-6.12 and N-17.02, found C-61.09, H-6.09 and N-16.80.",
            "cite_spans": [],
            "section": "2-(1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-N-(4-methoxyphenyl)hydrazinecarbothioamide (5c) ::: General procedure for syntheses of 5a\u2013h ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "% Yield: 67, m.p.: 191\u2013193 \u00b0C; IR (KBr) (cm\u22121): 1125 (C=S), 1297 (C\u2013N), 1706 (C=O), 3008 (C\u2013H), 3135, 3219 (NH); 1H-NMR (CDCl3) \u03b4 (ppm): 1.0 (t, 6H, 2CH3), 2.32 (s, 3H, CH3), 2.4 (q, 4H, 2CH2), 4.03 (s, 2H, N\u2013CH2), 6.3\u20137.7 (m, 9H, Ar\u2013H), 11.29 (s, 1H, N\u2013NH), 11.52 (s, 1H, NH); calc. for C21H25N5OS: C-63.77, H-6.37 and N-17.71, found C-63.42, H-6.14 and N-17.39.",
            "cite_spans": [],
            "section": "2-(1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-N-p-tolylhydrazinecarbothioamide (5d) ::: General procedure for syntheses of 5a\u2013h ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "% Yield: 72, m.p.: 181\u2013183 \u00b0C; IR (KBr) (cm\u22121): 1125 (C=S), 1315 (C\u2013N), 1718 (C=O), 3008 (C\u2013H), 3123, 3219 (NH); 1H-NMR (CDCl3) \u03b4 (ppm): 1.0 (t, 6H, 2CH3), 2.4 (q, 4H, 2CH2), 4.03 (s, 2H, N\u2013CH2), 6.9\u20137.7 (m, 8H, Ar\u2013H), 11.29 (s, 1H, N\u2013NH), 11.52 (s, 1H, NH); calc. for C20H22ClN5OS: C-57.75, H-5.33 and N-16.84, found C-57.51, H-5.37 and N-16.27.",
            "cite_spans": [],
            "section": "2-(5-chloro-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-N-phenylhydrazinecarbothioamide (5e) ::: General procedure for syntheses of 5a\u2013h ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "% Yield: 79, m.p.: 219\u2013221 \u00b0C; IR (KBr) (cm\u22121): 1114 (C=S), 1310 (C\u2013N), 1713 (C=O), 3007 (C\u2013H), 3123, 3216 (NH); 1H-NMR (CDCl3) \u03b4 (ppm): 1.0 (t, 6H, 2CH3), 2.4 (q, 4H, 2CH2), 4.03 (s, 2H, N\u2013CH2), 6.4\u20137.6 (m, 8H, Ar\u2013H), 11.29 (s, 1H, N\u2013NH), 11.52 (s, 1H, NH); calc. for C20H21Cl2N5OS: C-53.34, H-4.70 and N-15.55, found C-53.29, H-4.54 and N-15.28.",
            "cite_spans": [],
            "section": "2-(5-chloro-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-N-(4-chlorophenyl)hydrazinecarbothioamide (5f) ::: General procedure for syntheses of 5a\u2013h ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "% Yield: 73, m.p.: 165\u2013167 \u00b0C; IR (KBr) (cm\u22121): 1123 (C=S), 1329 (C\u2013N), 1716 (C=O), 3008 (C\u2013H), 3127, 3224 (NH); 1H-NMR (CDCl3) \u03b4 (ppm): 1.0 (t, 6H, 2CH3), 2.4 (q, 4H, 2CH2), 3.75 (s, 3H, O\u2013CH3), 4.03 (s, 2H, N\u2013CH2), 6.3\u20137.7 (m, 7H, Ar\u2013H), 11.29 (s, 1H, N\u2013NH), 11.52 (s, 1H, NH); calc. for C21H24ClN5O2S: C-56.56, H-5.42 and N-15.70, found C-56.26, H-5.32 and N-15.47.",
            "cite_spans": [],
            "section": "2-(5-chloro-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-N-(4-methoxyphenyl)hydrazinecarbothioamide (5g) ::: General procedure for syntheses of 5a\u2013h ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "% Yield: 72, m.p.: 178\u2013180 \u00b0C; IR (KBr) (cm\u22121): 1128 (C=S), 1309 (C\u2013N), 1711 (C=O), 3008 (C\u2013H), 3125, 3228 (NH); 1H-NMR (CDCl3) \u03b4 (ppm): 1.0 (t, 6H, 2CH3), 2.32 (s, 3H, CH3), 2.4 (q, 4H, 2CH2), 4.03 (s, 2H, N\u2013CH2), 6.3\u20137.7 (m, 8H, Ar\u2013H), 11.29 (s, 1H, N\u2013NH), 11.52 (s, 1H, NH); calc. for C21H24ClN5OS: C-58.66, H-5.63 and N-16.29, found C-58.43, H-5.38 and N-16.31.",
            "cite_spans": [],
            "section": "2-(5-chloro-1-((diethylamino)methyl)-2-oxoindolin-3-ylidene)-N-p-tolylhydrazinecarbothioamide (5h) ::: General procedure for syntheses of 5a\u2013h ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The antiviral screening of 4a, b and 5a\u2013h was performed against FIPV and feline herpes virus in CRFK cell culture; HSV-1 KOS, HSV-2G, VV, VSV, and HSV-1 TK KOS ACVr in HEL cell cultures; VSV, CVB4, and RSV in HeLa cell cultures; PI-3V, RV-1, SV, CV-B4, and PTV in Vero cell cultures; influenza A virus H1N1 subtype, influenza A virus H3N2 subtype, and influenza B virus in MDCK cell cultures and the results are expressed as the 50 % effective concentration (EC50). Cells, grown to confluency in 96-well plates, were infected with 100 CCID50 of virus, one CCID50 being the 50 % cell culture infective dose. At the time of virus infection, serial dilutions of the compounds were added. The cultures were incubated at 37 \u00b0C for 3 days, until complete CPE was observed in the infected and untreated virus control.",
            "cite_spans": [],
            "section": "Antiviral assay ::: Cytotoxicity assays ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The cytotoxicity of the compounds was evaluated in parallel with their antiviral activity in uninfected cells, and is expressed as the minimum cytotoxic concentration to cause a microscopically detectable alteration of normal cell morphology (HEL, HeLa, CRFK, MDCK, and Vero cells).",
            "cite_spans": [],
            "section": "Cytotoxicity assay ::: Cytotoxicity assays ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The cytostatic effects of the test compounds on murine leukemia cells (L1210), human T-lymphocyte cells (CEM), and human cervix carcinoma cells (HeLa) were evaluated as follows: an appropriate number of cells suspended in growth medium were allowed to proliferate in 200-\u03bcl wells of 96-well-microtiter plates in the presence of variable amounts of test compounds at 37 \u00b0C in a humidified CO2-controlled atmosphere. After 48 h (L1210), 72 h (CEM), or 96 h (HeLa), the number of cells was counted in a Coulter counter. The IC50 value was defined as the compound concentration required to inhibit cell proliferation by 50 %.",
            "cite_spans": [],
            "section": "Antiproliferative assays ::: Cytotoxicity assays ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Penicillinase activity is expressed in Pollock and Torriani unit. One unit is the amount of enzyme which will hydrolyze 1 \u03bcM Sodium Penicillin G in 1 h at pH 7.0 at 30 \u00b0C.",
            "cite_spans": [],
            "section": "Unit ::: \u03b2-lactamase inhibitory assay ::: Cytotoxicity assays ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The antimicrobial assays were performed for synthesized compounds by cup-plate method of all the synthesized compounds, as antibacterial activity against S. aureus, B. subtilis, K. pneumoniae, E. coli, P. vulgaris, and S. typhi and antifungal activity against A. niger and C. albicans. This activity was expressed in terms of diameters of zone of inhibition in mm.",
            "cite_spans": [],
            "section": "Antimicrobial screening ::: Cytotoxicity assays ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "In summary, a series of indolin-2-ones with N-diethyl amino and various thiosemicarbazide moiety were designed and synthesized. The cytotoxicity of all synthesized compounds was evaluated against two human cancer cell lines (CEM and HeLa) and murine leukemia cell line (L1210). Compound 5c displayed an excellent cytotoxicity against all three cell lines tested; in particular, it showed potent cytotoxicity against CEM and L1210 cancer cell lines. The preliminary structure\u2013activity relationship (SAR) studies revealed that combination of indolin-2-one core structure and 4-methoxy phenyl thiosemicarbazide moiety at the 3-position was more favorable. All the synthesized compounds were screened for cytotoxicity, \u03b2-lactamase inhibitory activity, antiviral, antibacterial, and antifungal activity against various strains of microorganisms. Derivative 4b, 5a, 5b, and 5d showed antiviral activity against HEL cell cultures in the range of 11\u201320 \u03bcM, in comparison with IC50 values of 29, 10, >250, and >100 \u03bcM for standard brivudin, cidofovir, acyclovir, and ganciclovir, respectively. Mild to moderate antimicrobial activity was observed. The encouraging biological data provide an adequate rationale for further modification of these molecular scaffolds.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table\u00a01: Results of cytotoxicity in murine L1210 cells, human HeLa, and CEM T-lymphocytes, and \u03b2-lactamase inhibitory activity\n\naIC50 concentrations of compounds required to inhibit the growth of the tumor cells by 50 %",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table\u00a02: Results of anti-FIPV and anti-feline herpes virus activity and cytotoxicity in CRFK cell cultures\n\na50 % cytotoxic concentration \nb50 % effective concentration, determined by colorimetric formazan-based MTS assay",
            "type": "table"
        },
        "TABREF2": {
            "text": "Table\u00a03: Results of cytotoxicity and antiviral activity of compounds in HEL cell cultures\n\naRequired to cause a microscopically detectable alteration of normal cell morphology \nbRequired to reduce virus-induced cytopathogenicity by 50 %",
            "type": "table"
        },
        "TABREF3": {
            "text": "Table\u00a04: Results of cytotoxicity and antiviral activity of compounds in HeLa cell cultures\n\na50 % cytotoxic concentration \nbMinimum compound concentration that causes a microscopically detectable alteration of normal cell morphology \nc50 % effective concentration, as determined by a colorimetric formazan-based MTS assay. Data in \u03bcg ml\u22121\n",
            "type": "table"
        },
        "TABREF4": {
            "text": "Table\u00a05: Results of cytotoxicity and antiviral activity of compounds in Vero cell cultures\n\naRequired to cause a microscopically detectable alteration of normal cell morphology \nbRequired to reduce virus-induced cytopathogenicity by 50 % \ncData in \u03bcg ml\u22121\n",
            "type": "table"
        },
        "TABREF5": {
            "text": "Table\u00a06: Results of anti-influenza virus activity and cytotoxicity in MDCK cell cultures\n\na50 % cytotoxic concentration, as determined by colorimetric formazan-based MTS assay \nbMinimum compound concentration that causes a microscopically detectable alteration of normal cell morphology \nc50 % effective concentration, as determined by colorimetric formazan-based MTS assay",
            "type": "table"
        },
        "TABREF6": {
            "text": "Table\u00a07: Zone of Inhibition in mm (using 50 \u03bcg ml\u22121 as test solution)\n++++ (31\u201336), +++ (21\u201330), ++ (11\u201320), + (8\u201310) in mm",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Fig.\u00a01: Structures of indolin-2-ones",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Scheme\u00a01: The reagents used were as follows: i CCl3CH(OH)2/H2SO4/Na2SO4; R\n1=H, Cl, ii (C2H5)NH/HCHO, iii NH2C(S)NHNH2, iv\nR\n2C6H4NHC(S)NHNH2. The nature of the R\n1 and R\n2 substituent are presented in Table 1\n",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Substituted E-3-(2-chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with antitumor activity. Effect on the cell cycle and apoptosis",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Andreani",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bellini",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Burnelli",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Granaiola",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Leoni",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Locatelli",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Morigi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rambaldi",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Varoli",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Calonghi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Cappadone",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zini",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Stefanelli",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Masotti",
                    "suffix": ""
                },
                {
                    "first": "RH",
                    "middle": [],
                    "last": "Shoemaker",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Med Chem",
            "volume": "53",
            "issn": "",
            "pages": "5567-5575",
            "other_ids": {
                "DOI": [
                    "10.1021/jm1007165"
                ]
            }
        },
        "BIBREF1": {
            "title": "Synthesis, structure\u2013activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mologni",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Rostagno",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Brussolo",
                    "suffix": ""
                },
                {
                    "first": "PP",
                    "middle": [],
                    "last": "Knowles",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kjaer",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Murray-Rust",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Rosso",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zambon",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Scapozza",
                    "suffix": ""
                },
                {
                    "first": "NQ",
                    "middle": [],
                    "last": "McDonald",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Lucchini",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Gambacorti-Passerini",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Bioorg Med Chem",
            "volume": "18",
            "issn": "",
            "pages": "1482-1496",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bmc.2010.01.011"
                ]
            }
        },
        "BIBREF2": {
            "title": "Synthesis and antimicrobial activity of N-Mannich bases of 3-[N\u2032-sulphadooximino] isatin and its methyl derivatives",
            "authors": [
                {
                    "first": "SN",
                    "middle": [],
                    "last": "Pandeya",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Yogeeswari",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sriram",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Nath",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Bull Chim Farm",
            "volume": "137",
            "issn": "",
            "pages": "321-324",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "Synthesis and screening for anti-HIV activity of some N-Mannich bases of isatin derivatives",
            "authors": [
                {
                    "first": "SN",
                    "middle": [],
                    "last": "Pandeya",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Yogeeswari",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sriram",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Pannecouque",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Witvrouw",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Chemother",
            "volume": "45",
            "issn": "",
            "pages": "192-196",
            "other_ids": {
                "DOI": [
                    "10.1159/000007182"
                ]
            }
        },
        "BIBREF4": {
            "title": "Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methylmercapto quinazolin-4(3H)-one",
            "authors": [
                {
                    "first": "SN",
                    "middle": [],
                    "last": "Pandeya",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sriram",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Nath",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Pharm Acta Helv",
            "volume": "74",
            "issn": "",
            "pages": "11-17",
            "other_ids": {
                "DOI": [
                    "10.1016/S0031-6865(99)00010-2"
                ]
            }
        },
        "BIBREF5": {
            "title": "Synthesis, antibacterial, antifungal and anti-HIV activities of Norfloxacin Mannich bases",
            "authors": [
                {
                    "first": "SN",
                    "middle": [],
                    "last": "Pandeya",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sriram",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Nath",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Eur J Med Chem",
            "volume": "35",
            "issn": "",
            "pages": "249-255",
            "other_ids": {
                "DOI": [
                    "10.1016/S0223-5234(00)00125-2"
                ]
            }
        },
        "BIBREF6": {
            "title": "Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120)",
            "authors": [
                {
                    "first": "GJ",
                    "middle": [],
                    "last": "Roth",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Heckel",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Colbatzky",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Handschuh",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kley",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Lehmann-Lintz",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lotz",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Tontsch-Grunt",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Walter",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Hilberg",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Med Chem",
            "volume": "52",
            "issn": "",
            "pages": "4466-4480",
            "other_ids": {
                "DOI": [
                    "10.1021/jm900431g"
                ]
            }
        },
        "BIBREF7": {
            "title": "Synthesis and antimicrobial activity of 1-[(N, N-disubstituted amino)methyl]-3-[(2-phenyl-3,4-dihydro-4-oxoquinazoline-3-yl]indole-2-one",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sarangapani",
                    "suffix": ""
                },
                {
                    "first": "VM",
                    "middle": [],
                    "last": "Reddy",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "Indian J Heterocycl Chem",
            "volume": "3",
            "issn": "",
            "pages": "257-260",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Possible antiamoebic agents. Part XIX. Synthesis of 1,3,4-thiadiazolines and di-1,3,4-thiadiazolines",
            "authors": [
                {
                    "first": "AB",
                    "middle": [],
                    "last": "Sen",
                    "suffix": ""
                },
                {
                    "first": "SK",
                    "middle": [],
                    "last": "Sengupta",
                    "suffix": ""
                }
            ],
            "year": 1962,
            "venue": "J Indian Chem Soc",
            "volume": "39",
            "issn": "",
            "pages": "628-634",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Synthesis of some 3-(4\u2032-nitrobenzoylhydrazono)-2-indolinones as a potential antiviral agents",
            "authors": [
                {
                    "first": "SP",
                    "middle": [],
                    "last": "Singh",
                    "suffix": ""
                },
                {
                    "first": "SK",
                    "middle": [],
                    "last": "Shukla",
                    "suffix": ""
                },
                {
                    "first": "LP",
                    "middle": [],
                    "last": "Awasthi",
                    "suffix": ""
                }
            ],
            "year": 1983,
            "venue": "Curr Sci",
            "volume": "52",
            "issn": "",
            "pages": "766-769",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "Transformation of isatin 3-acylhydrazones under acetylating conditions: synthesis and structure elucidation of 1,5\u2032-disubstituted 3\u2032-acetylspiro[oxindole-3,2\u2032-[1,3,4]oxadiazolines]",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Somogyi",
                    "suffix": ""
                }
            ],
            "year": 2001,
            "venue": "Bull Chem Soc Jpn",
            "volume": "74",
            "issn": "",
            "pages": "873-881",
            "other_ids": {
                "DOI": [
                    "10.1246/bcsj.74.873"
                ]
            }
        },
        "BIBREF11": {
            "title": "Design, syntheses and biological evaluation of hybrid molecules containing \u03b1-methylene-\u03b3-butyrolactones and polypyrrole minor groove binders",
            "authors": [
                {
                    "first": "PB",
                    "middle": [],
                    "last": "Baraldi",
                    "suffix": ""
                },
                {
                    "first": "MDelC",
                    "middle": [],
                    "last": "Nunez",
                    "suffix": ""
                },
                {
                    "first": "MA",
                    "middle": [],
                    "last": "Tabrizo",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Balzarini",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Bermejo",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Estevez",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Romagnoli",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Med Chem",
            "volume": "47",
            "issn": "",
            "pages": "2877-2886",
            "other_ids": {
                "DOI": [
                    "10.1021/jm031104y"
                ]
            }
        },
        "BIBREF12": {
            "title": "The wide pharmacological versatility of semicarbazones, thiosemicarbazones and their metal complexes",
            "authors": [
                {
                    "first": "SK",
                    "middle": [],
                    "last": "Sridhar",
                    "suffix": ""
                },
                {
                    "first": "SN",
                    "middle": [],
                    "last": "Pandeya",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Stables",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ramesh",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Eur J Med Chem",
            "volume": "16",
            "issn": "",
            "pages": "129-132",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin and its derivatives with triazole",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sriram",
                    "suffix": ""
                },
                {
                    "first": "SN",
                    "middle": [],
                    "last": "Pandeya",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Nath",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Arzneimittelforschung",
            "volume": "50",
            "issn": "",
            "pages": "55-59",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Discovery of 5-[5-fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2, 4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Liang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shirazian",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Miller",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cui",
                    "suffix": ""
                },
                {
                    "first": "JY",
                    "middle": [],
                    "last": "Fukuda",
                    "suffix": ""
                },
                {
                    "first": "JY",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nematalla",
                    "suffix": ""
                },
                {
                    "first": "XY",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sistla",
                    "suffix": ""
                },
                {
                    "first": "TC",
                    "middle": [],
                    "last": "Luu",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wei",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Med Chem",
            "volume": "46",
            "issn": "",
            "pages": "1116-1119",
            "other_ids": {
                "DOI": [
                    "10.1021/jm0204183"
                ]
            }
        },
        "BIBREF15": {
            "title": "Antiviral, antibacterial, and antifungal activities of isatin N-Mannich bases",
            "authors": [
                {
                    "first": "RS",
                    "middle": [],
                    "last": "Varma",
                    "suffix": ""
                },
                {
                    "first": "WL",
                    "middle": [],
                    "last": "Nobles",
                    "suffix": ""
                }
            ],
            "year": 1975,
            "venue": "J Pharm Sci",
            "volume": "64",
            "issn": "",
            "pages": "881-882",
            "other_ids": {
                "DOI": [
                    "10.1002/jps.2600640539"
                ]
            }
        },
        "BIBREF16": {
            "title": "Anticonvulsant activity of Schiff bases of isatin derivatives",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Varma",
                    "suffix": ""
                },
                {
                    "first": "SN",
                    "middle": [],
                    "last": "Pandeya",
                    "suffix": ""
                },
                {
                    "first": "KN",
                    "middle": [],
                    "last": "Singh",
                    "suffix": ""
                },
                {
                    "first": "JP",
                    "middle": [],
                    "last": "Stables",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Acta Pharm",
            "volume": "54",
            "issn": "",
            "pages": "49-56",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Xiao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Hao",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Qian",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Leuk Lymph",
            "volume": "43",
            "issn": "",
            "pages": "1763-1768",
            "other_ids": {
                "DOI": [
                    "10.1080/1042819021000006295"
                ]
            }
        },
        "BIBREF18": {
            "title": "Functionalized 3-benzylidene-indolin-2-ones: inducers of NAD(P)H-quinone oxidoreductase 1 (NQO1) with antiproliferative activity",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "ML",
                    "middle": [],
                    "last": "Go",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Bioorg Med Chem",
            "volume": "17",
            "issn": "",
            "pages": "2077-2090",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bmc.2008.12.052"
                ]
            }
        },
        "BIBREF19": {
            "title": "Synthesis and kinase inhibitory activity of novel substituted indigoids",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Beauchard",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Laborie",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Rouillard",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Lozach",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ferandin",
                    "suffix": ""
                },
                {
                    "first": "RL",
                    "middle": [],
                    "last": "Gue\u00b4vel",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Guguen-Guillouzo",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Meijer",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Besson",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Thie\u00b4ry",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Bioorg Med Chem",
            "volume": "17",
            "issn": "",
            "pages": "6257-6263",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bmc.2009.07.051"
                ]
            }
        },
        "BIBREF20": {
            "title": "Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexes",
            "authors": [
                {
                    "first": "SS",
                    "middle": [],
                    "last": "Karki",
                    "suffix": ""
                },
                {
                    "first": "UK",
                    "middle": [],
                    "last": "Mazumder",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gupta",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bhattacharya",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rathinasamy",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Thangavel",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Chem Pharm Bull",
            "volume": "52",
            "issn": "",
            "pages": "178-185",
            "other_ids": {
                "DOI": [
                    "10.1248/cpb.52.178"
                ]
            }
        },
        "BIBREF21": {
            "title": "Synthesis, anticancer and cytotoxic activities of some mononuclear Ru(II) compounds",
            "authors": [
                {
                    "first": "SS",
                    "middle": [],
                    "last": "Karki",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Shrikanth",
                    "suffix": ""
                },
                {
                    "first": "YD",
                    "middle": [],
                    "last": "Satyanarayana",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Balzarini",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Bioorg Med Chem",
            "volume": "15",
            "issn": "",
            "pages": "6632-6641",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bmc.2007.08.014"
                ]
            }
        },
        "BIBREF22": {
            "title": "1-Arylmethyl-2,3-dioxo-2,3-dihydroindole thiosemicarbazones as leads for developing cytotoxins and anticonvulsants",
            "authors": [
                {
                    "first": "SS",
                    "middle": [],
                    "last": "Karki",
                    "suffix": ""
                },
                {
                    "first": "VS",
                    "middle": [],
                    "last": "Bahaduria",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Rana",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "GS",
                    "middle": [],
                    "last": "Prasanna",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Das",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Balzarini",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                },
                {
                    "first": "JR",
                    "middle": [],
                    "last": "Dimmock",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "J Enzym Inhib Med Chem",
            "volume": "24",
            "issn": "",
            "pages": "537-544",
            "other_ids": {
                "DOI": [
                    "10.1080/14756360802234885"
                ]
            }
        },
        "BIBREF23": {
            "title": "Benzylidene/2-chlorobenzylidene hydrazides: synthesis, antimicrobial activity, QSAR studies and antiviral evaluation",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Judge",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Narang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sangwan",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Balzarini",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Narasimhan",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Eur J Med Chem",
            "volume": "45",
            "issn": "",
            "pages": "2806-2816",
            "other_ids": {
                "DOI": [
                    "10.1016/j.ejmech.2010.03.002"
                ]
            }
        },
        "BIBREF24": {
            "title": "Reactions of nitrous acid with 4-substituted thiosemicarbazides",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lieber",
                    "suffix": ""
                },
                {
                    "first": "ECN",
                    "middle": [],
                    "last": "Pillai",
                    "suffix": ""
                },
                {
                    "first": "RD",
                    "middle": [],
                    "last": "Hites",
                    "suffix": ""
                }
            ],
            "year": 1957,
            "venue": "Can J Chem",
            "volume": "35",
            "issn": "",
            "pages": "832-842",
            "other_ids": {
                "DOI": [
                    "10.1139/v57-116"
                ]
            }
        },
        "BIBREF25": {
            "title": "In isatin",
            "authors": [
                {
                    "first": "CS",
                    "middle": [],
                    "last": "Marvel",
                    "suffix": ""
                },
                {
                    "first": "GS",
                    "middle": [],
                    "last": "Heirs",
                    "suffix": ""
                }
            ],
            "year": 1941,
            "venue": "Organic syntheses collection",
            "volume": "",
            "issn": "",
            "pages": "327-330",
            "other_ids": {
                "DOI": []
            }
        }
    }
}